A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues a family physician and comparative effectiveness researcher.
A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues a family physician and comparative effectiveness researcher.